Cargando…

Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community

BACKGROUND: Trachoma, caused by Chlamydia trachomatis, remains the leading infectious cause of blindness worldwide. Persistence and progression of the resulting clinical disease appears to be an immunologically mediated process. Azithromycin, which is distributed at the community level for trachoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramadhani, Athumani M., Derrick, Tamsyn, Macleod, David, Massae, Patrick, Malisa, Aiweda, Mbuya, Kelvin, Mtuy, Tara, Makupa, William, Roberts, Chrissy H., Bailey, Robin L., Mabey, David C. W., Holland, Martin J., Burton, Matthew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658141/ https://www.ncbi.nlm.nih.gov/pubmed/31306419 http://dx.doi.org/10.1371/journal.pntd.0007559

Ejemplares similares

Progression of scarring trachoma in Tanzanian children: A four-year cohort study
por: Ramadhani, Athumani M., et al.
Publicado: (2019)

The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children
por: Pickering, Harry, et al.
Publicado: (2022)

Immunopathogenesis of Progressive Scarring Trachoma: Results of a 4-Year Longitudinal Study in Tanzanian Children
por: Derrick, Tamsyn, et al.
Publicado: (2020)

Immunofibrogenic Gene Expression Patterns in Tanzanian Children with Ocular Chlamydia trachomatis Infection, Active Trachoma and Scarring: Baseline Results of a 4-Year Longitudinal Study
por: Ramadhani, Athumani M., et al.
Publicado: (2017)

DjinniChip: evaluation of a novel molecular rapid diagnostic device for the detection of Chlamydia trachomatis in trachoma-endemic areas
por: Derrick, Tamsyn R., et al.
Publicado: (2020)

The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment
por: Ramadhani, Athumani M., et al.
Publicado: (2016)

Reduced-cost Chlamydia trachomatis-specific multiplex real-time PCR diagnostic assay evaluated for ocular swabs and use by trachoma research programmes
por: Butcher, Robert, et al.
Publicado: (2017)

Differential frequency of NKG2C/KLRC2 deletion in distinct African populations and susceptibility to Trachoma: a new method for imputation of KLRC2 genotypes from SNP genotyping data
por: Goncalves, Adriana, et al.
Publicado: (2016)

Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease
por: Ramadhani, Athumani M., et al.
Publicado: (2016)

Immunohistochemical Analysis of Scarring Trachoma Indicates Infiltration by Natural Killer and Undefined CD45 Negative Cells
por: Hu, Victor H., et al.
Publicado: (2016)

Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of Fiji
por: Macleod, Colin K., et al.
Publicado: (2016)

miRNAs that associate with conjunctival inflammation and ocular Chlamydia trachomatis infection do not predict progressive disease
por: Derrick, Tamsyn, et al.
Publicado: (2017)

Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands
por: Marks, M, et al.
Publicado: (2016)

Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
por: Hong, Kevin Cyrus, et al.
Publicado: (2009)

Chlamydia trachomatis ompA Variants in Trachoma: What Do They Tell Us?
por: Andreasen, Aura A., et al.
Publicado: (2008)

Active Trachoma and Ocular Chlamydia trachomatis Infection in Two Gambian Regions: On Course for Elimination by 2020?
por: Harding-Esch, Emma M., et al.
Publicado: (2009)

Risk Factors for Active Trachoma and Ocular Chlamydia trachomatis Infection in Treatment-Naïve Trachoma-Hyperendemic Communities of the Bijagós Archipelago, Guinea Bissau
por: Last, Anna R., et al.
Publicado: (2014)

Natural Products for the Treatment of Trachoma and Chlamydia trachomatis
por: Potroz, Michael G., et al.
Publicado: (2015)

Trachoma: Protective and Pathogenic Ocular Immune Responses to Chlamydia trachomatis
por: Hu, Victor H., et al.
Publicado: (2013)

In Vivo Confocal Microscopy in Scarring Trachoma
por: Hu, Victor H., et al.
Publicado: (2011)

Conjunctival transcriptome profiling of Solomon Islanders with active trachoma in the absence of Chlamydia trachomatis infection
por: Vasileva, Hristina, et al.
Publicado: (2018)

The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa
por: Last, Anna R., et al.
Publicado: (2017)

Spatial clustering of high load ocular Chlamydia trachomatis infection in trachoma: a cross-sectional population-based study
por: Last, Anna, et al.
Publicado: (2017)

Trachoma and Ocular Chlamydial Infection in the Era of Genomics
por: Derrick, Tamsyn, et al.
Publicado: (2015)

Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal
por: Harding-Esch, Emma M., et al.
Publicado: (2019)

Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-Naïve Trachoma-Endemic Region of the Solomon Islands
por: Butcher, Robert M. R., et al.
Publicado: (2016)

Trachoma, Anti-Pgp3 Serology, and Ocular Chlamydia trachomatis Infection in Papua New Guinea
por: Macleod, Colin K, et al.
Publicado: (2020)

Correction: Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-Naïve Trachoma-Endemic Region of the Solomon Islands
por: Butcher, Robert M. R., et al.
Publicado: (2016)

Clinical signs of trachoma are prevalent among Solomon Islanders who have no persistent markers of prior infection with Chlamydia trachomatis
por: Butcher, Robert, et al.
Publicado: (2018)

The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining
por: Rahman, Salman A., et al.
Publicado: (2015)

Profound and Sustained Reduction in Chlamydia trachomatis in The Gambia: A Five-Year Longitudinal Study of Trachoma Endemic Communities
por: Burton, Matthew J., et al.
Publicado: (2010)

Viability PCR shows that non-ocular surfaces could contribute to transmission of Chlamydia trachomatis infection in trachoma
por: Versteeg, Bart, et al.
Publicado: (2020)

Conjunctival FOXP3 Expression in Trachoma: Do Regulatory T Cells Have a Role in Human Ocular Chlamydia trachomatis Infection?
por: Faal, Nkoyo, et al.
Publicado: (2006)

Concordance of ompA types in children re-infected with ocular Chlamydia trachomatis following mass azithromycin treatment for trachoma
por: Mosenia, Arman, et al.
Publicado: (2022)

Serology for Trachoma Surveillance after Cessation of Mass Drug Administration
por: Martin, Diana L., et al.
Publicado: (2015)

Correction: The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining
por: Rahman, Salman A., et al.
Publicado: (2015)

Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma
por: Butcher, Robert, et al.
Publicado: (2020)

Non-Chlamydial Bacterial Infection and Progression of Conjunctival Scarring in Trachoma
por: Hu, Victor H., et al.
Publicado: (2018)

Pathogenesis of Progressive Scarring Trachoma in Ethiopia and Tanzania and Its Implications for Disease Control: Two Cohort Studies
por: Burton, Matthew J., et al.
Publicado: (2015)

Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
por: Ssemanda, Elizabeth N., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_djkpf8falr5sdv6l26kt1u0oh1